YZi Labs is pleased to announce that Jane He has joined as a Partner to lead our Biotech Investment practice.

BlockBeats News, March 21, YZi Labs announced that Jane He has joined as a General Partner to lead its biotechnology investments, while also contributing to YZi Labs' broader AI and Web3 strategy.

YZi Labs stated that following her graduation from Stanford University GSB, Jane has a strong track record in biotechnology and medical technology, actively seeking disruptive opportunities at the intersection of artificial intelligence and biotechnology. Her expertise covers areas such as cancer treatment, gene editing, metabolic therapy, and AI-driven biotechnological solutions, bringing a forward-looking approach to investments. Biotechnology is at the forefront of scientific innovation and will transform the broader human experience — from life-saving therapies to AI-driven medical breakthroughs. Jane's appointment reflects YZi Labs' strong commitment to supporting this transformative industry and advancing its development through visionary founders.